Canada markets closed

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6845-0.0055 (-0.80%)
At close: 04:00PM EDT
0.6800 -0.00 (-0.66%)
After hours: 04:14PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,573
8,573
63,573
20,340
0
Cost of Revenue
8,886
8,886
0
-
-
Gross Profit
-313
-313
63,573
-
-
Operating Expenses
Research Development
224,785
224,785
272,533
282,001
244,650
Selling General and Administrative
50,908
50,908
71,553
78,801
64,402
Total Operating Expenses
275,693
275,693
344,086
360,802
309,052
Operating Income or Loss
-276,006
-276,006
-280,513
-340,462
-309,052
Interest Expense
5,285
5,285
373
-
-
Total Other Income/Expenses Net
-246
-246
49,537
-
-
Income Before Tax
-276,111
-276,111
-228,290
-340,095
-306,605
Income Tax Expense
15
15
12
46
15
Income from Continuing Operations
-276,126
-276,126
-228,302
-340,141
-306,620
Net Income
-276,126
-276,126
-228,302
-340,141
-306,620
Net Income available to common shareholders
-276,126
-276,126
-228,302
-340,141
-306,620
Basic EPS
-2.78
-
-2.24
-3.63
-4.15
Diluted EPS
-2.78
-
-2.24
-3.63
-4.15
Basic Average Shares
104,670
-
101,990
93,670
73,973
Diluted Average Shares
104,670
-
101,990
93,670
73,973